Similar articles

Abstract: B cell lymphoma 2 (Bcl-2) is an important antiapoptotic gene that plays a dual role in the maintenance of the dynamic balance between the survival and death of cancer cells. In our previous study, Bcl-2 was shown to delay the G0/G1 to S phase entry by regulating the mitochondrial metabolic pathways to produce lower levels of adenosine triphosphate (ATP) and reactive oxygen species (ROS). However, the detailed molecular mechanisms or pathways by which Bcl-2 regulates the cell cycle remain unknown. Here, we compared the effects of Bcl-2 overexpression with an empty vector control in the NIH3T3 cell line synchronized by serum starvation, and evaluated the effects using proteomic analysis. The effect of Bcl-2 on cell cycle regulation was detected by monitoring Bcl-2 and p27 expression. The result of subsequent proteomic analysis of Bcl-2 overexpressing cells identified 169 upregulated and 120 downregulated proteins with a 1.5-fold change. These differentially expressed proteins were enriched in a number of signaling pathways predominantly involving the ribosome and oxidative phosphorylation, according to the data of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. These results indicated that Bcl-2 potentially acts at the translation level to influence proteins or enzymes of the respiratory chain or in the ribosome, and thereby regulates the cell cycle. Additionally, differentially expressed proteins involved in oxidative phosphorylation were determined to account for most of the effects of Bcl-2 on the cell cycle mediated by the mitochondrial pathway investigated in our previous study. These results can provide assistance for additional in-depth studies on the regulation of the cell cycle by Bcl-2. The results of the proteomic analysis determined the mechanism of Bcl-2-dependent delay of the cell cycle progression. In summary, the results of this study provide a novel mechanistic basis for identifying the key proteins or pathways for designing and developing precisely targeted cancer drugs.

Bcl-2调控细胞周期阻滞的蛋白质组学分析及其机制研究

[1]AdamsCM, Clark-GarveyS, PorcuP, et al., 2019. Targeting the Bcl-2 family in B cell lymphoma. Front Oncol, 8:636.

[2]Bonnefoy-BerardN, AouacheriaA, VerscheldeC, et al., 2004. Control of proliferation by Bcl-2 family members. Biochim Biophys Acta-Mol Cell Res, 1644(2-3):159-168.

[3]BradyHJ, Gil-GómezG, KirbergJ, et al., 1996. Baxα perturbs T cell development and affects cell cycle entry of T cells. EMBO J, 15(24):6991-7001.

[4]ClearyML, SmithSD, SklarJ, 1986. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell, 47(1):19-28.

[5]DelbridgeARD, GrabowS, StrasserA, et al., 2016. Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies. Nat Rev Cancer, 16(2):99-109.

[6]del Gaizo MooreV, LetaiA, 2013. BH3 profiling—measuring integrated function of the mitochondrial apoptotic pathway to predict cell fate decisions. Cancer Lett, 332(2):202-205.

[7]DuX, FuXF, YaoK, et al., 2017. Bcl-2 delays cell cycle through mitochondrial ATP and ROS. Cell Cycle, 16(7):707-713.

[8]FrantziM, LatosinskaA, MischakH, 2019. Proteomics in drug development: the dawn of a New Era? Proteomics Clin Appl, 13(2):e1800087.

[9]FuXF, YaoK, DuX, et al., 2016. PGC-1α regulates the cell cycle through ATP and ROS in CH1 cells. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 17(2):136-146.

[10]GaoSW, LiuF, 2019. Novel insights into cell cycle regulation of cell fate determination. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 20(6):467-475.

[11]GrossA, KatzSG, 2017. Non-apoptotic functions of BCL-2 family proteins. Cell Death Differ, 24(8):1348-1358.

[12]HatokJ, RacayP, 2016. Bcl-2 family proteins: master regulators of cell survival. Biomol Concepts, 7(4):259-270.

[13]HuSY, ZhuangQQ, QiuY, et al., 2019. Cell models and drug discovery for mitochondrial diseases. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 20(5):449-456.

[14]JanumyanYM, SansamCG, ChattopadhyayA, et al., 2003. Bcl-xL/Bcl-2 coordinately regulates apoptosis, cell cycle arrest and cell cycle entry. EMBO J, 22(20):5459-5470.

[15]JanumyanYM, CuiQH, YanL, et al., 2008. G₀ function of BCL2 and BCL-x_L requires BAX, BAK, and p27 phosphorylation by Mirk, revealing a novel role of BAX and BAK in quiescence regulation. J Biol Chem, 283(49):34108-34120.

[16]JardimFR, de AlmeidaFJS, LuckachakiMD, et al., 2020. Effects of sulforaphane on brain mitochondria: mechanistic view and future directions. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 21(4):263-279.

[17]KaleJ, OsterlundEJ, AndrewsDW, 2018. BCL-2 family proteins: changing partners in the dance towards death. Cell Death Differ, 25(1):65-80.

[18]KampenKR, SulimaSO, VerbelenB, et al., 2019. The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL. Leukemia, 33(2):319-332.

[19]KimHJ, MaitiP, BarrientosA, 2017. Mitochondrial ribosomes in cancer. Semin Cancer Biol, 47:67-81.

[20]KroemerG, GalluzziL, BrennerC, 2007. Mitochondrial membrane permeabilization in cell death. Physiol Rev, 87(1):99-163.

[21]LessardF, Brakier-GingrasL, FerbeyreG, 2019. Ribosomal proteins control tumor suppressor pathways in response to nucleolar stress. Bioessays, 41(3):e1800183.

[22]LiFD, WangYC, LiY, et al., 2018. Quantitative analysis of the global proteome in peripheral blood mononuclear cells from patients with new-onset psoriasis. Proteomics, 18(19):e1800003.

[23]LinetteGP, LiY, RothK, et al., 1996. Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc Natl Acad Sci USA, 93(18):9545-9552.

[24]MisraS, SharmaS, AgarwalA, et al., 2010. Cell cycle-dependent regulation of the bi-directional overlapping promoter of human BRCA2/ZAR2 genes in breast cancer cells. Mol Cancer, 9:50.

[25]PandeyS, PatilS, BallavN, et al., 2020. Spatial targeting of Bcl-2 on endoplasmic reticulum and mitochondria in cancer cells by lipid nanoparticles. J Mater Chem B, 8(19):4259-4266.

[26]PihánP, Carreras-SuredaA, HetzC, 2017. BCL-2 family: integrating stress responses at the ER to control cell demise. Cell Death Differ, 24(9):1478-1487.

[27]PopgeorgievN, JabbourL, GilletG, 2018. Subcellular localization and dynamics of the Bcl-2 family of proteins. Front Cell Dev Biol, 6:13.

[28]QuinnLM, RichardsonH, 2004. Bcl-2 in cell cycle regulation. Cell Cycle, 3(1):6-8.

[29]RobinsonBH, LuoXP, PitkänenS, et al., 1998. Diagnosis of mitochondrial energy metabolism defects in tissue culture. Induction of MnSOD and bcl-2 in mitochondria from patients with complex I (NADH-CoQ reductase) deficiency. Biofactors, 7(3):229-230.

[30]SinghR, LetaiA, SarosiekK, 2019. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat Rev Mol Cell Biol, 20(3):175-193.

[31]TaitSWG, GreenDR, 2010. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol, 11(9):621-632.

[32]TanakaS, SaitoK, ReedJC, 1993. Structure-function analysis of the Bcl-2 oncoprotein. Addition of a heterologous transmembrane domain to portions of the Bcl-2β protein restores function as a regulator of cell survival. J Biol Chem, 268(15):10920-10926.

[33]ThapaM, BommakantiA, ShamsuzzamanM, et al., 2013. Repressed synthesis of ribosomal proteins generates protein-specific cell cycle and morphological phenotypes. Mol Biol Cell, 24(23):3620-3633.

[34]TouzeauC, MaciagP, AmiotM, et al., 2018. Targeting Bcl-2 for the treatment of multiple myeloma. Leukemia, 32(9):1899-1907.

[35]VairoG, InnesKM, AdamsJM, 1996. Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival. Oncogene, 13(7):1511-1519.

[36]VairoG, SoosTJ, UptonTM, et al., 2000. Bcl-2 retards cell cycle entry through p27^Kip1, pRB relative p130, and altered E2F regulation. Mol Cell Biol, 20(13):4745-4753.

[37]WangCH, WangLK, WuCC, et al., 2019. The ribosomal protein RPLP0 mediates PLAAT4-induced cell cycle arrest and cell apoptosis. Cell Biochem Biophys, 77(3):253-260.

[38]WangYQ, LiuYH, WangS, et al., 2020. Hydrogen agronomy: research progress and prospects. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 21(11):841-855.

[39]WarrenCFA, Wong-BrownMW, BowdenNA, 2019. BCL-2 family isoforms in apoptosis and cancer. Cell Death Dis, 10(3):177.

[40]XieMH, YenY, OwonikokoTK, et al., 2014. Bcl2 induces DNA replication stress by inhibiting ribonucleotide reductase. Cancer Res, 74(1):212-223.

[41]XieMH, ParkD, SicaGL, et al., 2020. Bcl2-induced DNA replication stress promotes lung carcinogenesis in response to space radiation. Carcinogenesis, 41(11):1565-1575.

[42]XuHD, QinZH, 2019. Beclin 1, Bcl-2 and autophagy. Adv Exp Med Biol, 1206:109-126.

[43]ZhouFF, YangY, XingD, 2011. Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis. FEBS J, 278(3):403-413.